Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Erytech Pharma S.A.

Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2023
From Erytech Pharma S.A.
Via GlobeNewswire
PHAXIAM Therapeutics announces a reverse share split of its shares
From Erytech Pharma S.A.
Via GlobeNewswire
Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Responds to Akkadian’s Disinformation
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Provides Update on the Announced Combination with PHERECYDES
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Provides Business and Financial Update for the First Quarter of 2023
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
From Erytech Pharma S.A.
Via GlobeNewswire
ERYTECH Announces Receipt of Nasdaq Notice
From Erytech Pharma S.A.
Via GlobeNewswire
Monthly information related to total number of voting rights and shares composing the share capital _September 30, 2022
From Erytech Pharma S.A.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.